7 days ago
WGS
AnalystsDavid WestenbergDavid Westenberg's Stock Forecasts
AnalystsDavid Westenberg
Analyst Ranking
Top 9%
#449 out of 5020 analysts
Average Return
+13.13%
Win Rate
57%66 out of 115
Risk vs Reward
Poor
Good
David Westenberg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +204.75% | $42.33 | $129.00 | 2023-10-16 - 2024-10-15 | Strong Buy |
Natera IncNTRA | +133.26% | $47.08 | $109.82 | 2023-05-30 - 2024-05-29 | Strong Buy |
Neogenomics IncNEO | +122.80% | $8.07 | $17.98 | 2022-06-03 - 2023-06-02 | Strong Buy |
10x Genomics IncTXG | +114.33% | $72.59 | $155.58 | 2020-03-05 - 2021-03-05 | Strong Buy |
Guardant Health IncGH | +100.35% | $20.14 | $40.35 | 2024-02-26 - 2025-02-25 | Strong Buy |
David Westenberg Analyst Color
Get additional color on David Westenberg's coverage of popular stocks
a month ago
NTRA
a month ago
ADPT
a month ago
WGS
4 months ago
GH
7 months ago
TEM
7 months ago
NTRA
10 months ago
ADPT
a year ago
EXAS
a year ago
GH
a year ago
NTRA
a year ago
NTRA
2 years ago
ZTS
3 years ago
NVTAQ
3 years ago
CTKB
David Westenberg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Genedx Holdings CorpWGS | 3 | Strong Buy | $140.00 | +9.44% | Maintains | 7 days ago |
10x Genomics IncTXG | 2 | Hold | $15.00 | +16.64% | Initiates Coverage On | 7 days ago |
Pacific Biosciences Of California IncPACB | 9 | Hold | $1.50 | +21.95% | Maintains | a month ago |
Zoetis IncZTS | 12 | Strong Buy | $215.00 | +46.33% | Maintains | a month ago |
Idexx Laboratories IncIDXX | 8 | Hold | $700.00 | +9.23% | Maintains | a month ago |
Elanco Animal Health IncELAN | 10 | Hold | $18.00 | -2.33% | Maintains | a month ago |
Natera IncNTRA | 16 | Strong Buy | $220.00 | +25.41% | Maintains | a month ago |
Exact Sciences CorpEXAS | 11 | Strong Buy | $60.00 | +14.55% | Maintains | a month ago |
Adaptive Biotechnologies CorpADPT | 11 | Strong Buy | $15.00 | +17.00% | Maintains | a month ago |
Neogenomics IncNEO | 10 | Strong Buy | $11.00 | +35.64% | Maintains | a month ago |
Fulgent Genetics IncFLGT | 9 | Hold | $21.00 | -4.68% | Maintains | a month ago |
Tempus Ai IncTEM | 4 | Hold | $70.00 | -19.03% | Maintains | 4 months ago |
Illumina IncILMN | 15 | Strong Buy | $185.00 | +83.40% | Maintains | 4 months ago |
Labcorp Holdings IncLH | 4 | Hold | $280.00 | +1.42% | Maintains | 4 months ago |
Guardant Health IncGH | 9 | Strong Buy | $60.00 | +4.91% | Maintains | 4 months ago |
Quest Diagnostics IncDGX | 7 | Hold | $200.00 | +9.74% | Maintains | 5 months ago |
Neogen CorpNEOG | 12 | Hold | $5.00 | -8.42% | Maintains | 5 months ago |
Akoya Biosciences IncAKYA | 8 | Hold | $1.65 | +27.91% | Maintains | 5 months ago |
Cytek Biosciences IncCTKB | 9 | Strong Buy | $8.00 | +104.08% | Maintains | 7 months ago |
Insight Molecular Diagnostics IncIMDX | 7 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Invitae CorpNVTAQ | 5 | Strong Sell | $0.30 | N/A | Maintains | 2 years ago |
Heska CorpHSKA | 6 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Covetrus IncCVET | 1 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Petiq IncPETQ | 1 | Strong Buy | $44.00 | N/A | Maintains | 5 years ago |
Quidelortho CorpQDEL | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Trupanion IncTRUP | 1 | Hold | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.